Labianca R - Search Results

1

Evaluation of factors influencing 5-fluorouracil-induced diarrhea in colorectal cancer patients. An Italian Group for the Study of Digestive Tract Cancer (GISCAD) study.

Cascinu S, Barni S, Labianca R, Del Ferro E, Rocchi MB, Ligi M, Pessi MA, Cazzaniga M, Zamparelli G, Ardizzoia A, Ugolini G, Ghiandoni G, Luporini G, Catalano G. Cascinu S, et al. Among authors: labianca r. Support Care Cancer. 1997 Jul;5(4):314-7. doi: 10.1007/s005200050079. Support Care Cancer. 1997. PMID: 9257428 Clinical Trial.

2

High dose alpha-2b interferon + folinic acid in the modulation of 5-fluorouracil. A phase II study in advanced colorectal cancer with evidence of an unfavourable cost/benefit ratio.

Labianca R, Pancera G, Tedeschi L, Dallavalle G, Luporini A, Luporini G. Labianca R, et al. Tumori. 1992 Feb 29;78(1):32-4. doi: 10.1177/030089169207800107. Tumori. 1992. PMID: 1609456

3

Folinic acid + 5-fluorouracil (5-FU) versus equidose 5-FU in advanced colorectal cancer. Phase III study of 'GISCAD' (Italian Group for the Study of Digestive Tract Cancer).

Labianca R, Pancera G, Aitini E, Barni S, Beretta A, Beretta GD, Cesana B, Comella G, Cozzaglio L, Cristoni M, et al. Labianca R, et al. Ann Oncol. 1991 Oct;2(9):673-9. doi: 10.1093/oxfordjournals.annonc.a058047. Ann Oncol. 1991. PMID: 1742223 Free article. Clinical Trial.

4

Chemotherapy for patients not benefitting from 5-fluorouracil therapy.

Luporini G, Labianca R, Pancera G. Luporini G, et al. Among authors: labianca r. J Surg Oncol Suppl. 1991;2:161-4. doi: 10.1002/jso.2930480533. J Surg Oncol Suppl. 1991. PMID: 1892527 Review. No abstract available.

5

5-fluorouracil cardiotoxicity: the risk of rechallenge.

Labianca R, Luporini G. Labianca R, et al. Ann Oncol. 1991 May;2(5):383. Ann Oncol. 1991. PMID: 1954185 Free article. No abstract available.

6

Epirubicin treatment of advanced breast carcinoma with the weekly low-dose regimen.

Beretta G, Locatelli C, Tabiadon D, Labianca R, Fraschini P, Luporini G. Beretta G, et al. Among authors: labianca r. Oncology. 1987;44(1):6-12. doi: 10.1159/000226434. Oncology. 1987. PMID: 2436124

7

Cisplatin + 5-fluorouracil versus 5-fluorouracil alone in advanced colorectal cancer: a randomized study.

Labianca R, Pancera G, Cesana B, Clerici M, Montinari F, Luporini G. Labianca R, et al. Eur J Cancer Clin Oncol. 1988 Oct;24(10):1579-81. doi: 10.1016/0277-5379(88)90048-x. Eur J Cancer Clin Oncol. 1988. PMID: 3061823 Clinical Trial.

8

Confirmed activity of FAM polychemotherapy in advanced gastric carcinoma.

Fraschini P, Beretta G, Arnoldi E, Tedeschi L, Labianca R, Luporini G. Fraschini P, et al. Among authors: labianca r. Tumori. 1983 Feb 28;69(1):59-64. doi: 10.1177/030089168306900110. Tumori. 1983. PMID: 6687644

9

[The use of oral futraful as secondary treatment of patients with metastatic carcinoma].

Labianca R, Beretta G, Luporini G. Labianca R, et al. G Ital Chemioter. 1982 Jan-Jun;29(1):55-8. G Ital Chemioter. 1982. PMID: 6821043 Italian. No abstract available.

10

Antitumor chemotherapy after fluorouracil angina.

Beretta G, Labianca R, Montinari F, Luporini G. Beretta G, et al. Among authors: labianca r. J Cancer Res Clin Oncol. 1982;104(3):321-2. doi: 10.1007/BF00406251. J Cancer Res Clin Oncol. 1982. PMID: 7161314 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

362 results

Search Page

Filters